Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 177 citing articles:

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Alan Menter, Bruce Strober, Daniel H. Kaplan, et al.
Journal of the American Academy of Dermatology (2019) Vol. 80, Iss. 4, pp. 1029-1072
Closed Access | Times Cited: 730
Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies
Farzad Alinaghi, Monika Calov, Lars Erik Kristensen, et al.
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 1, pp. 251-265.e19
Open Access | Times Cited: 499
Pathogenesis of psoriasis and development of treatment
Eisaku Ogawa, Yuki Sato, Akane Minagawa, et al.
The Journal of Dermatology (2017) Vol. 45, Iss. 3, pp. 264-272
Open Access | Times Cited: 414
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2017)
Open Access | Times Cited: 301
Old and New Biological Therapies for Psoriasis
Kirsten Rønholt, Lars Iversen
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2297-2297
Open Access | Times Cited: 218
Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP
Hideki Fujita, Tadashi Terui, Koremasa Hayama, et al.
The Journal of Dermatology (2018) Vol. 45, Iss. 11, pp. 1235-1270
Open Access | Times Cited: 212
An update on generalized pustular psoriasis
Melinda Gooderham, Abby S. Van Voorhees, Mark Lebwohl
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 9, pp. 907-919
Open Access | Times Cited: 194
Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review
Masahiro Kamata, Yayoi Tada
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1690-1690
Open Access | Times Cited: 180
Paradoxical gastrointestinal effects of interleukin-17 blockers
Marine Fauny, David Moulin, Ferdinando D’Amico, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 9, pp. 1132-1138
Open Access | Times Cited: 180
Generalized pustular psoriasis: a review and update on treatment
Karl M. Hoegler, A.M. John, Marc Z. Handler, et al.
Journal of the European Academy of Dermatology and Venereology (2018) Vol. 32, Iss. 10, pp. 1645-1651
Closed Access | Times Cited: 173
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2020)
Open Access | Times Cited: 163
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2021) Vol. 2021, Iss. 12
Open Access | Times Cited: 134
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2022) Vol. 2022, Iss. 8
Open Access | Times Cited: 106
Treatment Options and Goals for Patients with Generalized Pustular Psoriasis
James G. Krueger, L. Puig, Diamant Thaçi
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. S1, pp. 51-64
Open Access | Times Cited: 95
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, Robin Guelimi, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 89
Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study
Shigetoshi Sano, Hiroshi Kubo, Hitomi Morishima, et al.
The Journal of Dermatology (2018) Vol. 45, Iss. 5, pp. 529-539
Open Access | Times Cited: 110
Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups
Bridget Kaufman, Andrew Alexis
American Journal of Clinical Dermatology (2017) Vol. 19, Iss. 3, pp. 405-423
Closed Access | Times Cited: 109
Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis
Michael J. Murphy, Jeffrey M. Cohen, Matthew D. Vesely, et al.
Journal of the American Academy of Dermatology (2020) Vol. 86, Iss. 5, pp. 1080-1091
Closed Access | Times Cited: 92
Efficacy and safety of risankizumab in Japanese patients with moderate to severe plaque psoriasis: Results from the Susta IMM phase 2/3 trial
Mamitaro Ohtsuki, Hideki Fujita, Masao Watanabe, et al.
The Journal of Dermatology (2019) Vol. 46, Iss. 8, pp. 686-694
Open Access | Times Cited: 77
Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis*
Kenneth B. Gordon, Mark Lebwohl, Kim Papp, et al.
British Journal of Dermatology (2021) Vol. 186, Iss. 3, pp. 466-475
Open Access | Times Cited: 74
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
Siew Eng Choon, Mark Lebwohl, Slaheddine Marrakchi, et al.
BMJ Open (2021) Vol. 11, Iss. 3, pp. e043666-e043666
Open Access | Times Cited: 65
Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review
Jörg C. Prinz, Siew Eng Choon, C.E.M. Griffiths, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 2, pp. 256-273
Open Access | Times Cited: 61
Clinical Disease Measures in Generalized Pustular Psoriasis
Andrea M. Burden, Siew Eng Choon, Alice B. Gottlieb, et al.
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. S1, pp. 39-50
Open Access | Times Cited: 46
Current management of generalized pustular psoriasis
Nilesh Kodali, Isabella Blanchard, Sruthi Kunamneni, et al.
Experimental Dermatology (2023) Vol. 32, Iss. 8, pp. 1204-1218
Open Access | Times Cited: 40
Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study
Boni E. Elewski, Mark Lebwohl, Milan J. Anadkat, et al.
Journal of the American Academy of Dermatology (2023) Vol. 89, Iss. 1, pp. 36-44
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top